Table 3.

Influence of demographic, lymphoma-specific, and HIV-specific factors on outcome



Overall survival
Prognostic factors
No.
Univariate HR*(95% CI)
Multivariate HR(95% CI)
Risk factor for HIV infection    
    Intravenous drug use   47  1§  1§ 
    Male homosexuality   22   2.41 (1.11-5.23)  2.34 (1.07-5.08) 
Histology    
    DLBCL   52  1§  1§ 
    Burkitt lymphoma   21   2.60 (1.20-5.64)  2.24 (1.01-4.97)# 
HIV viral load at the end of R-CDE    
    Undetectable   36  1§  1§ 
    Detectable
 
26
 
2.39 (1.10-5.18)
 
1.96 (0.88-4.36)**
 


Overall survival
Prognostic factors
No.
Univariate HR*(95% CI)
Multivariate HR(95% CI)
Risk factor for HIV infection    
    Intravenous drug use   47  1§  1§ 
    Male homosexuality   22   2.41 (1.11-5.23)  2.34 (1.07-5.08) 
Histology    
    DLBCL   52  1§  1§ 
    Burkitt lymphoma   21   2.60 (1.20-5.64)  2.24 (1.01-4.97)# 
HIV viral load at the end of R-CDE    
    Undetectable   36  1§  1§ 
    Detectable
 
26
 
2.39 (1.10-5.18)
 
1.96 (0.88-4.36)**
 
*

Cox proportional hazards model (HR and 95% CI).

Cox proportional hazards model, including only significant (P ≤ .05) prognostic factors in univariate analysis.

The sum does not add up to the total because of some missing values.

§

Reference category.

P = .03.

P = .02.

#

P = .05.

**

P = .10

or Create an Account

Close Modal
Close Modal